ARCHIVES

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

This article is from The Cancer Letter archive.

Vol. 33 No. 08 | March 2, 2007

Download PDF Visit The Full Archive

Related Articles

Professional societies: ACCC honors Clinton For Cancer Drug Initiatives, Insurance Bill

September 27, 1996

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

In Brief

February 7, 2014

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

November 27, 1992

NCI-supported meeting included tobacco industry representatives in dialogue on ethics.

October 29, 2004